ING posts FY2025 net result of €6,327 million, driven by continued growth in customer balances and fee income Full-year profit before tax of €9,148 million and full-year return on equity of ...
Piramal Pharma Limited (NSE: PPLPHARMA) (BSE: 543635), a leading global pharmaceutical, health and wellness company, today announced its standalone and consolidated results for the Third Quarter (Q3) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results